A weaning reaction to microbiota is required for resistance to immunopathologies in the adult Z Al Nabhani, S Dulauroy, R Marques, C Cousu, S Al Bounny, F Déjardin, ... Immunity 50 (5), 1276-1288. e5, 2019 | 511 | 2019 |
Imprinting of the immune system by the microbiota early in life Z Al Nabhani, G Eberl Mucosal immunology 13 (2), 183-189, 2020 | 208 | 2020 |
Nod2: The intestinal gate keeper Z Al Nabhani, G Dietrich, JP Hugot, F Barreau PLoS pathogens 13 (3), e1006177, 2017 | 187 | 2017 |
Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction U Meinzer, F Barreau, S Esmiol-Welterlin, C Jung, C Villard, T Leger, ... Cell host & microbe 11 (4), 337-351, 2012 | 144 | 2012 |
Altered gut microbiota composition in immune-impaired Nod2−/− mice S Mondot, F Barreau, Z Al Nabhani, M Dussaillant, K Le Roux, J Doré, ... Gut 61 (4), 634-635, 2012 | 109 | 2012 |
Nutritional strategies and gut microbiota composition as risk factors for necrotizing enterocolitis in very-preterm infants JC Rozé, PY Ancel, P Lepage, L Martin-Marchand, Z Al Nabhani, ... The American journal of clinical nutrition 106 (3), 821-830, 2017 | 94 | 2017 |
Nod2 Deficiency Leads to a Specific and Transmissible Mucosa-associated Microbial Dysbiosis Which Is Independent of the Mucosal Barrier Defect Z Al Nabhani, P Lepage, P Mauny, N Montcuquet, M Roy, K Le Roux, ... Journal of Crohn's and Colitis 10 (12), 1428-1436, 2016 | 60 | 2016 |
Yersinia pseudotuberculosis disrupts intestinal barrier integrity through hematopoietic TLR-2 signaling C Jung, U Meinzer, N Montcuquet, E Thachil, D Chateau, R Thiebaut, ... The Journal of clinical investigation 122 (6), 2239-2251, 2012 | 53 | 2012 |
NOD2 expression in intestinal epithelial cells protects toward the development of inflammation and associated carcinogenesis A Ferrand, Z Al Nabhani, NS Tapias, E Mas, JP Hugot, F Barreau Cellular and molecular gastroenterology and hepatology 7 (2), 357-369, 2019 | 51 | 2019 |
Excess calorie intake early in life increases susceptibility to colitis in adulthood Z Al Nabhani, S Dulauroy, E Lécuyer, B Polomack, P Campagne, ... Nature Metabolism 1 (11), 1101-1109, 2019 | 35 | 2019 |
Pseudomonas fluorescens Alters the Intestinal Barrier Function by Modulating IL-1β Expression Through Hematopoietic NOD2 Signaling Z Alnabhani, N Montcuquet, K Biaggini, M Dussaillant, M Roy, ... Inflammatory Bowel Diseases 21 (3), 543-555, 2015 | 33 | 2015 |
Respective roles of hematopoietic and nonhematopoietic Nod2 on the gut microbiota and mucosal homeostasis Z Alnabhani, JP Hugot, N Montcuquet, K Le Roux, M Dussaillant, M Roy, ... Inflammatory Bowel Diseases 22 (4), 763-773, 2016 | 32 | 2016 |
Complementary roles of Nod2 in hematopoietic and nonhematopoietic cells in preventing gut barrier dysfunction dependent on MLCK activity Z Al Nabhani, N Montcuquet, M Roy, M Dussaillant, JP Hugot, F Barreau Inflammatory bowel diseases 23 (7), 1109-1119, 2017 | 28 | 2017 |
Pseudomonas fluorescens can induce and divert the human β-defensin-2 secretion in intestinal epithelial cells to enhance its virulence A Madi, Z Alnabhani, C Leneveu, L Mijouin, M Feuilloley, N Connil Archives of microbiology 195, 189-195, 2013 | 21 | 2013 |
Nod2 protects the gut from experimental colitis spreading to small intestine Z Al Nabhani, D Berrebi, C Martinez-Vinson, N Montcuquet, C Madre, ... Journal of Crohn's and Colitis 14 (5), 669-679, 2020 | 6 | 2020 |
GAPs in early life facilitate immune tolerance Z Al Nabhani, G Eberl Science Immunology 2 (18), eaar2465, 2017 | 5 | 2017 |
Very preterm children gut Microbiota comparison at the neonatal period of 1 month and 3.5 years of life G Toubon, MJ Butel, JC Rozé, P Lepage, J Delannoy, PY Ancel, ... Frontiers in Microbiology 13, 919317, 2022 | 4 | 2022 |